FSSAI Suspends Dior Pharmaceuticals' Nutraceutical Licence in Punjab

Exam-focused facts from the 3 August 2026 current affairs briefing.

Key facts

The Food Safety and Standards Authority of India (FSSAI) suspended the nutraceutical manufacturing licence of Dior Pharmaceuticals.
The suspension followed inspection of the company's manufacturing unit in Punjab, which revealed serious non-compliances.
The unit was found operating under deficient Good Manufacturing Practices (GMP), Good Hygiene Practices (GHP), and Food Safety Management Systems (FSMS).
FSSAI stated that the deficiencies pose a significant risk to public health and constitute gross non-compliance with the FSS Act, 2006.
The licence was suspended with immediate effect, and the company was directed to cease all operations until all deficiencies are rectified.